Agreed - it's been way too long and way too many 'flavors of the month' for a lot of years.
The Monkey Pox trial "should" be running through its Phase 2a patient set in the DRC by now assuming that they actually got started during Mid April. If so - hopefully we should have some data on that cohort by the end of May. If what I read about the trial structure and timing was accurate, they were going to follow the patient treatment course for 28 days post-treatment.
Market Data 
Markets 
